229 related articles for article (PubMed ID: 18310086)
1. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.
Christensen BC; Godleski JJ; Marsit CJ; Houseman EA; Lopez-Fagundo CY; Longacker JL; Bueno R; Sugarbaker DJ; Nelson HH; Kelsey KT
Carcinogenesis; 2008 Aug; 29(8):1555-9. PubMed ID: 18310086
[TBL] [Abstract][Full Text] [Related]
2. Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.
Fujii M; Fujimoto N; Hiraki A; Gemba K; Aoe K; Umemura S; Katayama H; Takigawa N; Kiura K; Tanimoto M; Kishimoto T
Cancer Sci; 2012 Mar; 103(3):510-4. PubMed ID: 22146010
[TBL] [Abstract][Full Text] [Related]
3.
Cheng YY; Mok E; Tan S; Leygo C; McLaughlin C; George AM; Reid G
Dis Markers; 2017; 2017():2536187. PubMed ID: 29386699
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.
Christensen BC; Houseman EA; Godleski JJ; Marsit CJ; Longacker JL; Roelofs CR; Karagas MR; Wrensch MR; Yeh RF; Nelson HH; Wiemels JL; Zheng S; Wiencke JK; Bueno R; Sugarbaker DJ; Kelsey KT
Cancer Res; 2009 Jan; 69(1):227-34. PubMed ID: 19118007
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling of asbestos-treated MeT5A cell line reveals novel pathways implicated in asbestos response.
Casalone E; Allione A; Viberti C; Pardini B; Guarrera S; Betti M; Dianzani I; Aldieri E; Matullo G
Arch Toxicol; 2018 May; 92(5):1785-1795. PubMed ID: 29523930
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of malignant pleural mesothelioma.
Jaurand MC; Fleury-Feith J
Respirology; 2005 Jan; 10(1):2-8. PubMed ID: 15691231
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.
Ivanova AV; Ivanov SV; Prudkin L; Nonaka D; Liu Z; Tsao A; Wistuba I; Roth J; Pass HI
Mol Cancer; 2009 Oct; 8():91. PubMed ID: 19852844
[TBL] [Abstract][Full Text] [Related]
9. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.
Andujar P; Lacourt A; Brochard P; Pairon JC; Jaurand MC; Jean D
J Toxicol Environ Health B Crit Rev; 2016; 19(5-6):151-172. PubMed ID: 27705546
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I
Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.
Matullo G; Guarrera S; Betti M; Fiorito G; Ferrante D; Voglino F; Cadby G; Di Gaetano C; Rosa F; Russo A; Hirvonen A; Casalone E; Tunesi S; Padoan M; Giordano M; Aspesi A; Casadio C; Ardissone F; Ruffini E; Betta PG; Libener R; Guaschino R; Piccolini E; Neri M; Musk AW; de Klerk NH; Hui J; Beilby J; James AL; Creaney J; Robinson BW; Mukherjee S; Palmer LJ; Mirabelli D; Ugolini D; Bonassi S; Magnani C; Dianzani I
PLoS One; 2013; 8(4):e61253. PubMed ID: 23626673
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
[TBL] [Abstract][Full Text] [Related]
14. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
Girardi P; Bressan V; Merler E
Cancer Epidemiol; 2014 Oct; 38(5):496-503. PubMed ID: 25200195
[TBL] [Abstract][Full Text] [Related]
15. CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.
Kettunen E; Savukoski S; Salmenkivi K; Böhling T; Vanhala E; Kuosma E; Anttila S; Wolff H
BMC Cancer; 2019 May; 19(1):507. PubMed ID: 31138176
[TBL] [Abstract][Full Text] [Related]
16. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
[TBL] [Abstract][Full Text] [Related]
17. Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.
Hama R; Watanabe Y; Shinada K; Yamada Y; Ogata Y; Yoshida Y; Tamura T; Hiraishi T; Oikawa R; Sakurai J; Maehata T; Koizumi H; Itoh F
Tumour Biol; 2012 Dec; 33(6):2031-40. PubMed ID: 22836805
[TBL] [Abstract][Full Text] [Related]
18. MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Maille E; Brosseau S; Hanoux V; Creveuil C; Danel C; Bergot E; Scherpereel A; Mazières J; Margery J; Greillier L; Audigier-Valette C; Moro-Sibilot D; Molinier O; Corre R; Monnet I; Gounant V; Langlais A; Morin F; Levallet G; Zalcman G
Br J Cancer; 2019 Feb; 120(4):387-397. PubMed ID: 30739911
[TBL] [Abstract][Full Text] [Related]
19. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
Lin RT; Chang YY; Wang JD; Lee LJ
J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure.
Metintas M; Metintas S; Ak G; Erginel S; Alatas F; Kurt E; Ucgun I; Yildirim H
Respirology; 2008 Jan; 13(1):117-21. PubMed ID: 18197921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
